Detalles de la búsqueda
1.
Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report.
J Immunother Cancer
; 9(1)2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33431630
Resultados
1 -
1
de 1
1
Próxima >
>>